The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC-MS characterization, and In-vitro safety evaluation.
Saved in:
| Title: | The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC-MS characterization, and In-vitro safety evaluation. |
|---|---|
| Authors: | Abdallah IA; Department of Analytical Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City, 32897 Egypt., El-Behairy MF; Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City, 32897 Egypt., Ahmed RM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Misr International University, Cairo, Egypt., Fayed MAA; Department of Pharmacognosy, Faculty of Pharmacy, University of Sadat City, Sadat City, 32897 Egypt. |
| Source: | Chemicke zvesti [Chem Zvesti] 2022; Vol. 76 (10), pp. 6415-6426. Date of Electronic Publication: 2022 Jul 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: De Gruyter Country of Publication: Germany NLM ID: 0066560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0366-6352 (Print) Linking ISSN: 03666352 NLM ISO Abbreviation: Chem Zvesti Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
